Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
ClinicalTrials.gov
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
OBSERVATIONAL
Inicio: 1 de jun de 2014
ID: NCT02188355
Completado
Fase 3
ClinicalTrials.gov
A Safety and Efficacy Trial Evaluating the Use of Apixaban for the Extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00633893
Completado
Fase 4
ClinicalTrials.gov
A Randomised, Controlled, Open Label, Multicentre, Multinational, Treat-to-target Trial Investigating the Efficacy and Safety of Intensification With Addition of Bolus Insulin Aspart in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin With or Without Oral Anti-diabetic Drugs: Step-wise Addition Versus Complete Basal-bolus Therapy
INTERVENTIONAL
Inicio: 1 de oct de 2010
ID: NCT01165684
Completado
Fase 3
ClinicalTrials.gov
A Phase III Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0g Idarucizumab (BI 655075) in Patients Treated Wtih Dabigatran Etexilate Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures.RE-VERSE AD (A Study of the RE-VERSal Effects of Idarucizumab on Active Dabigatran) Trial
INTERVENTIONAL
Inicio: 6 de may de 2014
ID: NCT02104947
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Double-dummy, Placebo Controlled, Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy After Twelve Weeks of Treatment, Compared to Placebo and Etanercept, and to Assess the Safety, Tolerability and Long-term Efficacy up to One Year in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
INTERVENTIONAL
Inicio: 1 de jun de 2011
ID: NCT01358578
Completado
Fase 1
ClinicalTrials.gov
A Phase I Study to Assess The Safety and Pharmacokinetics of BB-10901 (huN901-DM1) Given as an Intravenous Infusion Weekly for Two Consecutive Weeks Every Three Weeks to Subjects With Relapsed and Relapsed Refractory CD56-Positive Multiple Myeloma
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00346255
Completado
ClinicalTrials.gov
Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients
INTERVENTIONAL
Inicio: 1 de may de 2023
ID: NCT05680363
Completado
Fase 2
ClinicalTrials.gov
Study AZ3110866, a Fixed Dose Study of SB-742457 Versus Placebo When Added to Existing Donepezil Treatment in Subjects With Mild-to-moderate Alzheimer's Disease
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00710684
Completado
ClinicalTrials.gov
Non Ablative Erbium:YAG Laser Transurethral Treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Younger Patients: a Prospective Comparative Study
INTERVENTIONAL
Inicio: 13 de mar de 2017
ID: NCT04446598
Completado
Fase 1
ClinicalTrials.gov
Non-blinded, Randomized, Single Center, Single Dose, Cross-over Study to Assess the Effect of a High Calorie/High Fat Meal on the Pharmacokinetics of Four 30 mg Nifurtimox Tablets Taken Orally by Adult Male and Female Patients Suffering From Chronic Chagas' Disease
INTERVENTIONAL
Inicio: 1 de dic de 2015
ID: NCT02606864
Terminado
Fase 3
ClinicalTrials.gov
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
INTERVENTIONAL
Inicio: 30 de abr de 2010
ID: NCT01121536
Completado
Fase 3
ClinicalTrials.gov
PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial
INTERVENTIONAL
Inicio: 14 de ago de 2020
ID: NCT04460651
Completado
ClinicalTrials.gov
NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin®
OBSERVATIONAL
Inicio: 1 de abr de 2006
ID: NCT00960128
Completado
Fase 1
ClinicalTrials.gov
Open Label, Randomized, Single-dose, Cross-over Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg Tablets, Administered to Adult Male and Female Patients With Chagas' Disease
INTERVENTIONAL
Inicio: 14 de jun de 2018
ID: NCT03350295
Terminado
Fase 1
ClinicalTrials.gov
A Phase 1b, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With RSV Infection
INTERVENTIONAL
Inicio: 4 de dic de 2015
ID: NCT02593851
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 12 de jul de 2012
ID: NCT01639339
Desconocido
ClinicalTrials.gov
Nutritional Status and Family Strategies Linked to Feeding in Children and Adolescents With Cerebral Palsy.
OBSERVATIONAL
Inicio: 1 de mar de 2019
ID: NCT04179422
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor Rilzabrutinib (PRN1008) in Moderate to Severe Pemphigus
INTERVENTIONAL
Inicio: 8 de ene de 2019
ID: NCT03762265
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART
INTERVENTIONAL
Inicio: 1 de abr de 2015
ID: NCT02454556
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01499277
Anterior
1
...
414
415
416
...
434
Siguiente
Filtros